ABOUT NEVNUCLAB
NEVNUCLAB is a next-generation nuclear medicine company accelerating access to critical medical isotopes through a scalable, outsourced, and regulation-ready model. Founded in 2023 and headquartered in the United States, we collaborate with premier public labs to identify, produce, and deliver high-value isotopes like Actinium-225, Copper-67, and Strontium-82. Unlike traditional infrastructure-heavy providers, our model bypasses costly bottlenecks by leveraging public infrastructure, streamlining regulatory processes, and managing the full supply chain from lab to clinic. Our mission is to close global supply gaps, empower research and treatment, and redefine what’s possible in nuclear medicine.
Our Mission
Nevnuclab bridges cutting-edge nuclear research and the rising demand for next-generation medical isotopes.
We fast-track the production and delivery of isotopes like Actinium-225 and Copper-64, enabling breakthrough therapies and diagnostics.
Our outsourced, scalable model removes the need for heavy infrastructure, accelerating time to market and expanding global access to life-saving treatments.
We exist to turn scientific potential into clinical reality efficiently, safely, and globally.
What We Do
NEVNUCLAB accelerates global access to advanced medical isotopes by rethinking how nuclear medicine supply chains operate. Through strategic partnerships with world-renowned public labs, we identify and fast-track critical isotopes—such as Ac-225, Cu-67, and Sr-82—from research to real-world clinical use. Our outsourced, regulation-ready model eliminates infrastructure bottlenecks, allowing us to deliver life-saving isotopes faster, more efficiently, and at scale. From research institutions to hospitals and pharma, we serve as a trusted partner across the entire value chain.
Our Team
NEVNUCLAB is driven by a cross-functional team of nuclear scientists, and regulatory strategists. We combine decades of experience across the nuclear industry. Our leadership includes former program leads from US and European nuclear labs, experts in radiation physics and isotope, and legal and compliance professionals with deep nuclear licensing experience
We’re not just building a company—we’re accelerating a new supply chain in the isotopes industry. Our team is united by a shared belief: that access to life-saving isotopes shouldn’t be bottlenecked by outdated systems.
At NEVNUCLAB, we bring execution speed, scientific credibility, and a global network, turning nuclear innovation into reality.
Our Values
At Nevnuclab, we are driven by:
- Scientific Integrity – We work alongside top labs and institutions to translate advanced nuclear research into tangible impact.
- Access & Equity – We aim to democratize access to cutting-edge radiotherapies by improving supply chains and reducing entry barriers.
- Efficiency & Focus – We follow a lean operational model, outsourcing production and logistics to scale without owning the isotopes ourselves.
- Collaboration – Our model is built on partnerships with national labs, chemical processors, and distributors to deliver results fast and reliably.
Our Commitment
At NEVNUCLAB, we are committed to bridging the gap between innovation and access in nuclear medicine. We believe life-saving isotopes should not be limited by infrastructure, geography, or outdated supply chains. That’s why we’ve built a model that prioritizes speed, scalability, and scientific integrity—empowering researchers, clinicians, and institutions around the world to advance diagnostics and treatments without delay. Our commitment is to every patient waiting for a breakthrough and every partner working to deliver it.
